Raymond James & Associates’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,270
| Closed | -$407K | – | 3970 |
|
|
2023
Q4 | $407K | Sell |
7,270
-873
| -11% | -$48.9K | ﹤0.01% | 3057 |
|
|
2023
Q3 | $336K | Sell |
8,143
-2,760
| -25% | -$114K | ﹤0.01% | 3119 |
|
|
2023
Q2 | $609K | Buy |
+10,903
| New | +$609K | ﹤0.01% | 2785 |
|
|
2023
Q1 | – | Sell |
-35,123
| Closed | -$1.28M | – | 3924 |
|
|
2022
Q4 | $1.28M | Sell |
35,123
-10,531
| -23% | -$384K | ﹤0.01% | 2285 |
|
|
2022
Q3 | $1.3M | Sell |
45,654
-5,151
| -10% | -$147K | ﹤0.01% | 2235 |
|
|
2022
Q2 | $2.3M | Sell |
50,805
-2,204
| -4% | -$99.7K | ﹤0.01% | 1902 |
|
|
2022
Q1 | $4.03M | Buy |
53,009
+8,570
| +19% | +$652K | ﹤0.01% | 1665 |
|
|
2021
Q4 | $6.62M | Buy |
44,439
+37,999
| +590% | +$5.66M | 0.01% | 1351 |
|
|
2021
Q3 | $938K | Sell |
6,440
-2,874
| -31% | -$419K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $1.82M | Sell |
9,314
-12,593
| -57% | -$2.47M | ﹤0.01% | 2160 |
|
|
2021
Q1 | $3.97M | Sell |
21,907
-2,129
| -9% | -$385K | ﹤0.01% | 1575 |
|
|
2020
Q4 | $3.4M | Buy |
24,036
+18,254
| +316% | +$2.58M | ﹤0.01% | 1556 |
|
|
2020
Q3 | $721K | Buy |
5,782
+3,284
| +131% | +$410K | ﹤0.01% | 2372 |
|
|
2020
Q2 | $223K | Sell |
2,498
-11,534
| -82% | -$1.03M | ﹤0.01% | 3049 |
|
|
2020
Q1 | $874K | Buy |
+14,032
| New | +$874K | ﹤0.01% | 2067 |
|